# EDGAR Filing Document

**Accession Number:** 0001791827
**File Stem:** 0001085146-25-005637
**Filing Date:** 2025-8
**Character Count:** 35500
**Document Hash:** 3afd5be26ed8ee30a4b9be12f1830659
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001085146-25-005637.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001085146-25-005637

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**EFFECTIVENESS DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Avidity Partners Management LP
- **CENTRAL INDEX KEY:** 0001791827

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-20028
- **FILM NUMBER:** 251277940

**BUSINESS ADDRESS:**
- **STREET 1:** 2828 N HARWOOD STREET
- **STREET 2:** SUITE 1220
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75201
- **BUSINESS PHONE:** 214-550-1822

**MAIL ADDRESS:**
- **STREET 1:** 2828 N HARWOOD STREET
- **STREET 2:** SUITE 1220
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75201

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001791827

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Avidity Partners Management LP

**Address:** 2828 N HARWOOD STREET, DALLAS, TX 75201

**Telephone number:** 214-550-1696

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-20028

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                              | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                     | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| Jazz Pharmaceuticals Public Limited Company | G50871105 | 07/25/2024     | To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc s named executive officers as disclosed in the proxy statement.                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         377459 |                0 | FOR         |                                   377459 | FOR                         |  |
| Jazz Pharmaceuticals Public Limited Company | G50871105 | 07/25/2024     | To indicate, on a non-binding advisory basis, the preferred frequency of the advisory vote on the compensation of Jazz Pharmaceuticals plc s named executive officers.                                                                               | SECTION 14A SAY-ON-PAY VOTES |         377459 |                0 | 1 YEAR      |                                   377459 | FOR                         |  |
| Immunovant, Inc.                            | 45258J102 | 08/12/2024     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         316823 |                0 | FOR         |                                   316823 | FOR                         |  |
| ARCA Biopharma, Inc.                        | 00211Y506 | 08/22/2024     | To approve, on an advisory basis, certain compensation arrangements for ARCA named executive officers that are based on or otherwise relate to the Merger.                                                                                           | SECTION 14A SAY-ON-PAY VOTES |        1000000 |                0 | FOR         |                                  1000000 | FOR                         |  |
| bluebird bio, Inc.                          | 09609G100 | 12/04/2024     | The approval, on a non-binding, advisory basis, of the compensation of our named executive officers.                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         459246 |                0 | AGAINST     |                                   459246 | AGAINST                     |  |
| Humana Inc.                                 | 444859102 | 04/17/2025     | Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2025 proxy statement.                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |          44649 |                0 | FOR         |                                    44649 | FOR                         |  |
| Molina Healthcare, Inc.                     | 60855R100 | 04/30/2025     | To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |          10660 |                0 | AGAINST     |                                    10660 | AGAINST                     |  |
| Boston Scientific Corporation               | 101137107 | 05/01/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         320000 |                0 | FOR         |                                   320000 | FOR                         |  |
| Intuitive Surgical, Inc.                    | 46120E602 | 05/01/2025     | To approve, by advisory vote, the compensation of the Company's Named Executive Officers.                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |          23700 |                0 | FOR         |                                    23700 | FOR                         |  |
| Biohaven Ltd.                               | G1110E107 | 05/05/2025     | A non-binding advisory vote on the compensation of the Company's named executive officers.                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         154656 |                0 | AGAINST     |                                   154656 | AGAINST                     |  |
| Danaher Corporation                         | 235851102 | 05/06/2025     | To approve on an advisory basis the Company's named executive officer compensation.                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          44500 |                0 | FOR         |                                    44500 | FOR                         |  |
| Alnylam Pharmaceuticals, Inc.               | 02043Q107 | 05/08/2025     | To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          24986 |                0 | FOR         |                                    24986 | FOR                         |  |
| Avantor, Inc.                               | 05352A100 | 05/08/2025     | Approve, on an Advisory Basis, Named Executive Officer Compensation.                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         396726 |                0 | FOR         |                                   396726 | FOR                         |  |
| DexCom, Inc.                                | 252131107 | 05/08/2025     | To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2024.                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         180000 |                0 | FOR         |                                   180000 | FOR                         |  |
| AbbVie Inc.                                 | 00287Y109 | 05/09/2025     | Say on Pay - An advisory vote on the approval of executive compensation                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          87664 |                0 | FOR         |                                    87664 | FOR                         |  |
| Royalty Pharma Plc                          | G7709Q104 | 05/12/2025     | A non-binding advisory vote to approve executive compensation that may become payable in connection with the transaction contemplated by the Membership Interest Purchase Agreement.                                                                 | SECTION 14A SAY-ON-PAY VOTES |         139169 |                0 | FOR         |                                   139169 | FOR                         |  |
| Royalty Pharma Plc                          | G7709Q104 | 05/12/2025     | A non-binding advisory vote to approve executive compensation.                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |         139169 |                0 | AGAINST     |                                   139169 | AGAINST                     |  |
| Syndax Pharmaceuticals, Inc.                | 87164F105 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement.                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         925000 |                0 | FOR         |                                   925000 | FOR                         |  |
| Vera Therapeutics, Inc.                     | 92337R101 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          91000 |                0 | FOR         |                                    91000 | FOR                         |  |
| Vera Therapeutics, Inc.                     | 92337R101 | 05/14/2025     | To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          91000 |                0 | 1 YEAR      |                                    91000 | FOR                         |  |
| Insmed Incorporated                         | 457669307 | 05/15/2025     | An advisory vote on the 2024 compensation of our named executive officers.                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          70171 |                0 | FOR         |                                    70171 | FOR                         |  |
| Ultragenyx Pharmaceutical Inc.              | 90400D108 | 05/15/2025     | Advisory (non-binding) vote to approve the compensation of our named executive officers.                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         322100 |                0 | FOR         |                                   322100 | FOR                         |  |
| Neurocrine Biosciences, Inc.                | 64125C109 | 05/21/2025     | Advisory vote on the compensation paid to the Company's named executive officers.                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          85700 |                0 | FOR         |                                    85700 | FOR                         |  |
| Thermo Fisher Scientific Inc.               | 883556102 | 05/21/2025     | An advisory vote to approve named executive officer compensation.                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          15386 |                0 | AGAINST     |                                    15386 | AGAINST                     |  |
| Capricor Therapeutics, Inc.                 | 14070B309 | 05/22/2025     | Aapproval of named executive officer compensation, on a non-binding advisory basis.                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         101429 |                0 | FOR         |                                   101429 | FOR                         |  |
| Dianthus Therapeutics, Inc.                 | 252828108 | 05/22/2025     | To approve, on an advisory basis, the compensation paid to our named executive officers.                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |          40000 |                0 | FOR         |                                    40000 | FOR                         |  |
| Tenet Healthcare Corporation                | 88033G407 | 05/22/2025     | To approve, on an advisory basis, the Company's executive compensation.                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          66134 |                0 | FOR         |                                    66134 | FOR                         |  |
| Karyopharm Therapeutics Inc.                | 48576U205 | 05/28/2025     | To Approve, On An Advisory Basis, The Compensation Of Our Named Executive Officers, As Described In The Proxy Statement.                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         134566 |                0 | FOR         |                                   134566 | FOR                         |  |
| Karyopharm Therapeutics Inc.                | 48576U205 | 05/28/2025     | To Recommend, On An Advisory Basis, The Frequency Of Future Non-Binding Advisory Votes On The Compensation Of Our Named Executive Officers.                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |         134566 |                0 | 1 YEAR      |                                   134566 | FOR                         |  |
| Perspective Therapeutics, Inc.              | 46489V302 | 05/28/2025     | To consider and vote on a proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.                                                                      | SECTION 14A SAY-ON-PAY VOTES |        2197270 |                0 | FOR         |                                  2197270 | FOR                         |  |
| agilon health, inc.                         | 00857U107 | 05/28/2025     | To approve, by advisory vote, the compensation paid to the Company's named executive officers.                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |         305100 |                0 | AGAINST     |                                   305100 | AGAINST                     |  |
| ACADIA Pharmaceuticals Inc.                 | 004225108 | 05/29/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         185000 |                0 | FOR         |                                   185000 | FOR                         |  |
| Bruker Corporation                          | 116794108 | 05/29/2025     | Approval on an advisory basis of the 2024 compensation of our named executive officers, as discussed in the Proxy Statement.                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |         114516 |                0 | FOR         |                                   114516 | FOR                         |  |
| Glaukos Corporation                         | 377322102 | 05/29/2025     | Approval, on an advisory basis, of the compensation of the Company"s named executive officers.                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |          95000 |                0 | FOR         |                                    95000 | FOR                         |  |
| Mirum Pharmaceuticals, Inc.                 | 604749101 | 05/29/2025     | To approve, on an advisory basis, the compensation of the Company s named executive officers, as disclosed in the proxy statement.                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          40000 |                0 | FOR         |                                    40000 | FOR                         |  |
| REGENXBIO Inc.                              | 75901B107 | 05/30/2025     | Advisory vote on the compensation paid to the Company's named executive officers.                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         260000 |                0 | FOR         |                                   260000 | FOR                         |  |
| REGENXBIO Inc.                              | 75901B107 | 05/30/2025     | Advisory vote on the frequency of future stockholder advisory votes on the compensation paid to the Company's named executive officers.                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         260000 |                0 | 1 YEAR      |                                   260000 | FOR                         |  |
| Oruka Therapeutics, Inc.                    | 687604108 | 06/02/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         352124 |                0 | FOR         |                                   352124 | FOR                         |  |
| Oruka Therapeutics, Inc.                    | 687604108 | 06/02/2025     | To vote, on a non-binding, advisory basis, on the frequency of future advisory votes to approve compensation for our named executive officers.                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |         352124 |                0 | 1 YEAR      |                                   352124 | FOR                         |  |
| UnitedHealth Group Incorporated             | 91324P102 | 06/02/2025     | Advisory approval of the Company's executive compensation.                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          49611 |                0 | FOR         |                                    49611 | FOR                         |  |
| Akero Therapeutics, Inc.                    | 00973Y108 | 06/03/2025     | To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers.                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          43914 |                0 | FOR         |                                    43914 | FOR                         |  |
| Phathom Pharmaceuticals, Inc.               | 71722W107 | 06/03/2025     | To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay").                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |         800000 |                0 | AGAINST     |                                   800000 | AGAINST                     |  |
| Phathom Pharmaceuticals, Inc.               | 71722W107 | 06/03/2025     | To approve a proposal for the frequency of future non-binding advisory votes on the compensation of the named executive officers ("say-on-frequency").                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         800000 |                0 | 1 YEAR      |                                   800000 | FOR                         |  |
| Beam Therapeutics Inc.                      | 07373V105 | 06/04/2025     | Approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         559517 |                0 | FOR         |                                   559517 | FOR                         |  |
| Xenon Pharmaceuticals Inc.                  | 98420N105 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Corporation's named executive officers;                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         191200 |                0 | FOR         |                                   191200 | FOR                         |  |
| Ionis Pharmaceuticals, Inc.                 | 462222100 | 06/05/2025     | To make an advisory vote on executive compensation.                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          55446 |                0 | FOR         |                                    55446 | FOR                         |  |
| Teva Pharmaceutical Industries Ltd.         | 881624209 | 06/05/2025     | To approve, on a non-binding advisory basis, the compensation for Teva's named Executive Officers                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         689500 |                0 | FOR         |                                   689500 | FOR                         |  |
| Axsome Therapeutics, Inc.                   | 05464T104 | 06/06/2025     | To approve, by non-binding advisory vote, the compensation of our named executive officers.                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          66423 |                0 | FOR         |                                    66423 | FOR                         |  |
| Organon  Co.                                | 68622V106 | 06/10/2025     | Approve, on a non-binding advisory basis, the compensation of Organon's Named Executive Officers.                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         524293 |                0 | AGAINST     |                                   524293 | AGAINST                     |  |
| Janux Therapeutics, Inc.                    | 47103J105 | 06/11/2025     | Approval, on an advisory basis, of the compensation of our named executive officers ( Say-On-Pay ), as disclosed in the accompanying Proxy Statement.                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         192000 |                0 | FOR         |                                   192000 | FOR                         |  |
| Janux Therapeutics, Inc.                    | 47103J105 | 06/11/2025     | Indication, on an advisory basis, of the preferred frequency of holding future Say-On-Pay votes on the compensation of our named executive officers.                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         192000 |                0 | 1 YEAR      |                                   192000 | FOR                         |  |
| uniQure N.V.                                | N90064101 | 06/11/2025     | Approval, on an advisory basis, of the compensation of the named executive officers of the Company.                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          94017 |                0 | AGAINST     |                                    94017 | AGAINST                     |  |
| Arcutis Biotherapeutics, Inc.               | 03969K108 | 06/12/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         169979 |                0 | FOR         |                                   169979 | FOR                         |  |
| Exact Sciences Corporation                  | 30063P105 | 06/12/2025     | To approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         269400 |                0 | FOR         |                                   269400 | FOR                         |  |
| Natera, Inc.                                | 632307104 | 06/12/2025     | To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         146697 |                0 | FOR         |                                   146697 | FOR                         |  |
| Regeneron Pharmaceuticals, Inc.             | 75886F107 | 06/13/2025     | Proposal to approve, on an advisory basis, executive compensation.                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          14200 |                0 | FOR         |                                    14200 | FOR                         |  |
| Kezar Life Sciences, Inc.                   | 49372L209 | 06/17/2025     | Advisory vote on the compensation paid to our named executive officers.                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         478528 |                0 | FOR         |                                   478528 | FOR                         |  |
| Blueprint Medicines Corporation             | 09627Y109 | 06/18/2025     | Approval of a non-binding advisory vote on the compensation paid to our named executive officers.                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          66326 |                0 | FOR         |                                    66326 | FOR                         |  |
| BridgeBio Pharma, Inc.                      | 10806X102 | 06/20/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          56767 |                0 | AGAINST     |                                    56767 | AGAINST                     |  |
| Madrigal Pharmaceuticals, Inc.              | 558868105 | 06/20/2025     | Advisory vote to approve executive compensation.                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |           8728 |                0 | FOR         |                                     8728 | FOR                         |  |
| Madrigal Pharmaceuticals, Inc.              | 558868105 | 06/20/2025     | Advisory vote to approve the frequency of future advisory votes to approve executive compensation.                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |           8728 |                0 | 1 YEAR      |                                     8728 | FOR                         |  |
| IDEAYA Biosciences, Inc.                    | 45166A102 | 06/24/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders.                                             | SECTION 14A SAY-ON-PAY VOTES |         355000 |                0 | AGAINST     |                                   355000 | AGAINST                     |  |
| Arvinas, Inc.                               | 04335A105 | 06/25/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |         381162 |                0 | AGAINST     |                                   381162 | AGAINST                     |  |
| SCYNEXIS, Inc.                              | 811292200 | 06/25/2025     | To vote, on an advisory basis, on the compensation paid to SCYNEXIS, Inc.'s named executive officers.                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |        1156806 |                0 | FOR         |                                  1156806 | FOR                         |  |
| HealthEquity, Inc.                          | 42226A107 | 06/26/2025     | To approve, on a non-binding, advisory basis, the fiscal 2025 compensation paid to our named executive officers.                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          48397 |                0 | FOR         |                                    48397 | FOR                         |  |
| Revolution Medicines, Inc.                  | 76155X100 | 06/26/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). | SECTION 14A SAY-ON-PAY VOTES |         111100 |                0 | FOR         |                                   111100 | FOR                         |  |
| United Therapeutics Corporation             | 91307C102 | 06/26/2025     | Advisory resolution to approve executive compensation.                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |          16800 |                0 | FOR         |                                    16800 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Avidity Partners Management LP

**By (Signature):** Charles Hoedebeck

**By (Printed Signature):** Charles Hoedebeck

**By (Title):** Chief Financial Officer

**Date:** 08/29/2025